Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-25
SponsorChildren's Mercy Hospital Kansas City

About this trial

The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents \& young adults (16-25 years old) with Type 1 Diabetes (T1D).

The main questions it aims to answer are:

* Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it? * Do patients and healthcare providers like using the spotlight AQ survey?

Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey.

Eligibility criteria

Qualifiers

16-25 years old

Patients diagnosed with T1D for at least 6 months

On any diabetes treatment

Using a Continuous Glucose Monitor (CGM)

Disqualifiers

<16 years old or >25 years old

Mental illness that could seriously reduce their ability to participate in the study

Lack of capacity

In another T1D intervention study

Trial design

Treatments tested in this trial

  • Spotlight AQ Survey platform

Treatment groups

60 Participants
are divided into 2 treatment groups